Medicine and Dentistry
Visual Acuity
100%
Glaucoma
37%
Docetaxel
34%
Telehealth
34%
Retinal Detachment
34%
Contrast Sensitivity
34%
Hypotony Maculopathy
34%
Electronic Health Record
34%
Wet Macular Degeneration
34%
Home Monitoring
34%
Iridotomy
34%
Gemcitabine
34%
COVID-19
34%
Age Related Macular Degeneration
34%
Vision
34%
Pars Plana
34%
Papilledema
34%
Artery Occlusion
34%
Effusion
27%
Combination Therapy
15%
Diagnosis Code
13%
Agents Acting on the Eye
13%
B-Scan Ultrasonography
13%
Best Corrected Visual Acuity
12%
Choroidal Neovascularization
11%
Surgery
8%
Adverse Event
8%
Central Retinal Vein Occlusion
8%
Magnetic Resonance Imaging
8%
Capillary
8%
Epileptic Absence
8%
Artery
8%
Optic Nerve
8%
Clinical Feature
8%
Drug Megadose
8%
Systemic Disease
8%
Vasculitis
8%
Giant-Cell Arteritis
8%
Fluorescein Angiography
8%
Multimodal Imaging
8%
Vein Occlusion
8%
Cancer Prevention
6%
Sarcoma
6%
Monotherapy
6%
Cross Sectional Study
6%
Finger
6%
Combination Chemotherapy
6%
Slit Lamp Microscopy
6%
Division
6%
Photoreceptor Inner Segment
6%
Keyphrases
Home Monitoring Devices
34%
Electronic Health Records
34%
Hypotony Maculopathy
34%
Contrast Sensitivity Test
34%
Hyaloidotomy
34%
Malignant Glaucoma
34%
Gemcitabine Chemotherapy
34%
Injection Force
34%
Cilioretinal Artery Occlusion
34%
Optic Disc Edema
34%
Clinical Notes
25%
Retina
17%
Diagnostic Codes
17%
Dellen
11%
Injection Speed
11%
Progress Notes
8%
Electronic Health Record Data
8%
Manual Review
8%
Footnotes
8%
Peripheral Iridotomy
8%
Financial Disclosure
8%
Finger Counting
8%
Gemcitabine Monotherapy
8%
Fluorescein Angiography
8%
High-dose Corticosteroids
8%
Hand Motion
8%
Capillary Nonperfusion
8%
Retrospective Chart Review
8%
Multimodal Imaging
8%
Systemic Disease
8%
Non-contributory
8%
Lost to Follow-up
8%
Visual Acuity
8%
Giant Cell Arteritis
8%
Retinal Whitening
8%
Retinal Thinning
8%
Optic Nerve
8%
Vein Occlusion
8%
Clinical Features
8%
Retinal Vein Occlusion
8%
Vascular Inflammation
8%
Presenting Visual Acuity
8%
Magnetic Resonance Imaging
8%
Cilioretinal Artery
8%
Intravitreal Aflibercept
5%
Nursing and Health Professions
Age Related Macular Degeneration
36%
Visual Impairment
34%
Syringe
34%
Electronic Health Record
34%
Home Monitoring
34%
Wet Macular Degeneration
34%
Visual Acuity
34%
Aflibercept
34%
Reference Value
17%
Hospital
12%
Subretinal Neovascularization
11%
Progress Note
6%
Cross-Sectional Study
6%
Drusen
5%
